Abstract:AIM: To explore how specific malonyl-CoA-acyl carrier protein transacylase (MCAT) mutations (L81R/R212W) influence mitochondrial fusion and fission, clarifying their pathogenic mechanisms in hereditary optic neuropathy. METHODS: Wild-type (WT) and L81R/R212W mutant MCAT were expressed in human embryonic kidney 293T (HEK293T) cells and zebrafish embryos. Mitochondrial fusion and fission were evaluated by Western blotting, polyethylene glycol (PEG)-induced fusion assays, and immunofluorescence. Ultrastructural changes and retinal morphology were assessed via transmission electron microscopy (TEM) to investigate the impact of MCAT mutations on mitochondrial dynamics in vivo and in vitro. RESULTS: MCAT-L81R/R212W mutations led to selective impairment of mitochondrial fusion, evidenced by decreased expression of mitofusin 1 (MFN1), mitofusin 2 (MFN2), and optic atrophy 1 (OPA1), while fission proteins dynamin-related protein 1 (DRP1) and mitochondrial fission factor (MFF) remained unaffected. PEG-induced mitochondrial fusion assays showed defective mitochondrial fusion in mutant cells. In zebrafish models, the mutation resulted in reduced eye size, disorganized retinal ganglion cells (RGCs) layers, and mitochondrial abnormalities, including fragmentation, cristae disorganization, and outer membrane rupture. Translocase of outer membrane 20 (TOM20) expression was also reduced, indicating compromised mitochondrial membrane integrity. CONCLUSION: MCAT-L81R/R212W mutations may predominantly impair mitochondrial fusion, while exerting relatively limited effects on fission, with no marked changes in DRP1 and MFF expression. These findings suggest that MCAT-dependent mitochondrial fatty acid synthesis may contribute to mitochondrial fusion competence, membrane integrity, and retinal development, although the direct causal relationship requires further investigation.